The impact of competing risks on the observed rate of chronic hepatitis C progression

W. Ray Kim, John J. Poterucha, Joanne T. Benson, Terry M Therneau

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Background & aims In previous studies about the natural history of chronic hepatitis C (CHC), age at the time of infection correlated with the rate at which hepatic fibrosis progresses. The presence of a competing risk, namely higher mortality from natural causes, may contribute to this observation. A simulation experiment was conducted to measure the magnitude of the effect of competing risks on the observed rate of fibrosis progression of CHC. Methods A computer-based probabilistic model was created in which fibrosis of CHC progressed from stage 0 to 4 (cirrhosis) in 20-year-old and 50-year-old male and female cohorts. The rate of fibrosis progression was randomly assigned to each simulated individual from a distribution common to all age- and sex-specific cohorts. The cohorts also experienced mortality from natural causes according to the 2000 census data. Results The observed median time to reach cirrhosis for the 50-year-old cohorts was 20.4 ± 0.2 years compared with 29.7 ± 0.2 for the 20-year-old cohorts (P < 0.01). The median time to reach cirrhosis in men was 24.2 ± 0.6 years compared with 25.9 ± 0.6 in women (P = 0.01). Overall, the observed rate of progression was slowest among young women. Similarly, accelerating mortality from natural causes, simulating the impact of comorbid conditions that shorten survival, reduced the observed time to reach cirrhosis. Conclusions Even if the underlying rate of fibrosis progression in CHC was held constant, the time to reach cirrhosis will be observed to be substantially shorter in subjects with a higher competing mortality.

Original languageEnglish (US)
Pages (from-to)749-755
Number of pages7
JournalGastroenterology
Volume127
Issue number3
DOIs
StatePublished - Sep 2004

Fingerprint

Chronic Hepatitis C
Fibrosis
Mortality
Statistical Models
Censuses
Survival
Liver

ASJC Scopus subject areas

  • Gastroenterology

Cite this

The impact of competing risks on the observed rate of chronic hepatitis C progression. / Kim, W. Ray; Poterucha, John J.; Benson, Joanne T.; Therneau, Terry M.

In: Gastroenterology, Vol. 127, No. 3, 09.2004, p. 749-755.

Research output: Contribution to journalArticle

Kim, W. Ray ; Poterucha, John J. ; Benson, Joanne T. ; Therneau, Terry M. / The impact of competing risks on the observed rate of chronic hepatitis C progression. In: Gastroenterology. 2004 ; Vol. 127, No. 3. pp. 749-755.
@article{ec3bc4602a3d49c78a43223de998a959,
title = "The impact of competing risks on the observed rate of chronic hepatitis C progression",
abstract = "Background & aims In previous studies about the natural history of chronic hepatitis C (CHC), age at the time of infection correlated with the rate at which hepatic fibrosis progresses. The presence of a competing risk, namely higher mortality from natural causes, may contribute to this observation. A simulation experiment was conducted to measure the magnitude of the effect of competing risks on the observed rate of fibrosis progression of CHC. Methods A computer-based probabilistic model was created in which fibrosis of CHC progressed from stage 0 to 4 (cirrhosis) in 20-year-old and 50-year-old male and female cohorts. The rate of fibrosis progression was randomly assigned to each simulated individual from a distribution common to all age- and sex-specific cohorts. The cohorts also experienced mortality from natural causes according to the 2000 census data. Results The observed median time to reach cirrhosis for the 50-year-old cohorts was 20.4 ± 0.2 years compared with 29.7 ± 0.2 for the 20-year-old cohorts (P < 0.01). The median time to reach cirrhosis in men was 24.2 ± 0.6 years compared with 25.9 ± 0.6 in women (P = 0.01). Overall, the observed rate of progression was slowest among young women. Similarly, accelerating mortality from natural causes, simulating the impact of comorbid conditions that shorten survival, reduced the observed time to reach cirrhosis. Conclusions Even if the underlying rate of fibrosis progression in CHC was held constant, the time to reach cirrhosis will be observed to be substantially shorter in subjects with a higher competing mortality.",
author = "Kim, {W. Ray} and Poterucha, {John J.} and Benson, {Joanne T.} and Therneau, {Terry M}",
year = "2004",
month = "9",
doi = "10.1053/j.gastro.2004.06.052",
language = "English (US)",
volume = "127",
pages = "749--755",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - The impact of competing risks on the observed rate of chronic hepatitis C progression

AU - Kim, W. Ray

AU - Poterucha, John J.

AU - Benson, Joanne T.

AU - Therneau, Terry M

PY - 2004/9

Y1 - 2004/9

N2 - Background & aims In previous studies about the natural history of chronic hepatitis C (CHC), age at the time of infection correlated with the rate at which hepatic fibrosis progresses. The presence of a competing risk, namely higher mortality from natural causes, may contribute to this observation. A simulation experiment was conducted to measure the magnitude of the effect of competing risks on the observed rate of fibrosis progression of CHC. Methods A computer-based probabilistic model was created in which fibrosis of CHC progressed from stage 0 to 4 (cirrhosis) in 20-year-old and 50-year-old male and female cohorts. The rate of fibrosis progression was randomly assigned to each simulated individual from a distribution common to all age- and sex-specific cohorts. The cohorts also experienced mortality from natural causes according to the 2000 census data. Results The observed median time to reach cirrhosis for the 50-year-old cohorts was 20.4 ± 0.2 years compared with 29.7 ± 0.2 for the 20-year-old cohorts (P < 0.01). The median time to reach cirrhosis in men was 24.2 ± 0.6 years compared with 25.9 ± 0.6 in women (P = 0.01). Overall, the observed rate of progression was slowest among young women. Similarly, accelerating mortality from natural causes, simulating the impact of comorbid conditions that shorten survival, reduced the observed time to reach cirrhosis. Conclusions Even if the underlying rate of fibrosis progression in CHC was held constant, the time to reach cirrhosis will be observed to be substantially shorter in subjects with a higher competing mortality.

AB - Background & aims In previous studies about the natural history of chronic hepatitis C (CHC), age at the time of infection correlated with the rate at which hepatic fibrosis progresses. The presence of a competing risk, namely higher mortality from natural causes, may contribute to this observation. A simulation experiment was conducted to measure the magnitude of the effect of competing risks on the observed rate of fibrosis progression of CHC. Methods A computer-based probabilistic model was created in which fibrosis of CHC progressed from stage 0 to 4 (cirrhosis) in 20-year-old and 50-year-old male and female cohorts. The rate of fibrosis progression was randomly assigned to each simulated individual from a distribution common to all age- and sex-specific cohorts. The cohorts also experienced mortality from natural causes according to the 2000 census data. Results The observed median time to reach cirrhosis for the 50-year-old cohorts was 20.4 ± 0.2 years compared with 29.7 ± 0.2 for the 20-year-old cohorts (P < 0.01). The median time to reach cirrhosis in men was 24.2 ± 0.6 years compared with 25.9 ± 0.6 in women (P = 0.01). Overall, the observed rate of progression was slowest among young women. Similarly, accelerating mortality from natural causes, simulating the impact of comorbid conditions that shorten survival, reduced the observed time to reach cirrhosis. Conclusions Even if the underlying rate of fibrosis progression in CHC was held constant, the time to reach cirrhosis will be observed to be substantially shorter in subjects with a higher competing mortality.

UR - http://www.scopus.com/inward/record.url?scp=4444356823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444356823&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2004.06.052

DO - 10.1053/j.gastro.2004.06.052

M3 - Article

C2 - 15362031

AN - SCOPUS:4444356823

VL - 127

SP - 749

EP - 755

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 3

ER -